Honghui Huang - Concepedia

Author

Honghui Huang

Also Known As

H Huang, H. Huang, HONG-HUI HUANG, Hong-Hui Huang, Hong-hui Huang, Honghui Huang, Hong‐Hui Huang, Huang Honghui, Huang, Hong-Hui, Huang, Honghui

Publications

761

Citations

H-Index

Concepts

All Affiliations

Renji Hospital Shanghai Jiao Tong University Second Military Medical University Sun Yat-sen University

About

Honghui Huang is an author at Renji Hospital specializing in medicine, cancer research, and tumor biology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	245
2	Immunology	4	4	149
3	Cell Biology	2	2	68
4	Health Sciences	1	1	24
5	Epidemiology	1	1	18

Honghui Huang

Publications

513

Citations

H-Index

Page 1

	Year	Citations
Hsa-miR-24-3p increases nasopharyngeal carcinoma radiosensitivity by targeting both the 3′UTR and 5′UTR of Jab1/CSN5 Sumei Wang, Yunbao Pan, R Zhang, Oncogene Tumor BiologyRadiation MedicineMedicineCancer Cell BiologyPathology	2016	96
Prognostic value of total lesion glycolysis of baseline 18F-fluorodeoxyglucose positron emission tomography/computed tomography in diffuse large B-cell lymphoma Mingge Zhou, Yumei Chen, Honghui Huang, Oncotarget	2016	64
Clinical and prognostic significance of miR-155 and miR-146a expression levels in formalin-fixed/paraffin-embedded tissue of patients with diffuse large B-cell lymphoma Hua Zhong, Lan Xu, Jihua Zhong, Experimental and Therapeutic Medicine ImmunologyPathologyMir-146a Expression LevelsPrognostic SignificanceTumor Biology	2012	63
Single-cell RNA sequencing reveals XBP1-SLC38A2 axis as a metabolic regulator in cytotoxic T lymphocytes in multiple myeloma Yike Wan, Mengping Chen, Xin Li, Cancer Letters Hematological MalignancySystems BiologyReveals Xbp1-slc38a2 AxisMalignant Blood DisorderImmunology	2023	44
SLC29A1 single nucleotide polymorphisms as independent prognostic predictors for survival of patients with acute myeloid leukemia: an in vitro study Haixia Wan, Jianyi Zhu, Fangyuan Chen, Journal of Experimental & Clinical Cancer Research	2014	31
Bortezomib, Melphalan, and Prednisone With or Without Daratumumab in Transplant-ineligible Asian Patients With Newly Diagnosed Multiple Myeloma: The Phase 3 OCTANS Study Weijun Fu, Soo‐Mee Bang, Honghui Huang, Clinical Lymphoma Myeloma & Leukemia	2023	30
Single‐cell transcriptome profiling reveals the key role of ZNF683 in natural killer cell exhaustion in multiple myeloma Xin Li, Mengping Chen, Yike Wan, Clinical and Translational Medicine	2022	29
Glycolytic inhibitor 2-deoxy-<scp>d</scp>-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC Yuyang Pang, Ting Wang, Fangyuan Chen, Leukemia & lymphoma/Leukemia and lymphoma ImmunologyNhl ProgressionCell ProliferationMetabolic RemodelingCancer Biology	2014	24
Correlation of pretreatment 18F-FDG uptake with clinicopathological factors and prognosis in patients with newly diagnosed diffuse large B-cell lymphoma Honghui Huang, Fei Xiao, Xiaofeng Han, Nuclear Medicine Communications	2016	21
C-reactive protein impairs immune response of CD8<sup>+</sup> T cells via FcγRIIb-p38MAPK-ROS axis in multiple myeloma Jinxing Jiang, Ziyi Peng, Junying Wang, Journal for ImmunoTherapy of Cancer	2023	19

Page 1